{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:38:07Z","timestamp":1777408687820,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00415-023-12145-8","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T17:03:03Z","timestamp":1704819783000},"page":"1707-1716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9728-8773","authenticated-orcid":false,"given":"Oskar","family":"McWilliam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias H.","family":"Gramkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Blaabjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederikke Kragh","family":"Clemmensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen G.","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian Steen","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"12145_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575\u2013586. https:\/\/doi.org\/10.1016\/S1474-4422(14)70051-1","journal-title":"Lancet Neurol"},{"key":"12145_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.str.2019.03.004","volume":"27","author":"FM Ranaivoson","year":"2019","unstructured":"Ranaivoson FM, Turk LS, Ozgul S et al (2019) A proteomic screen of neuronal cell-surface molecules reveals IgLONs as structurally conserved interaction modules at the synapse. Structure 27:893-906.e9. https:\/\/doi.org\/10.1016\/j.str.2019.03.004","journal-title":"Structure"},{"key":"12145_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736\u20131743. https:\/\/doi.org\/10.1212\/WNL.0000000000003887","journal-title":"Neurology"},{"key":"12145_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, H\u00f6ftberger R, Graus F et al (2016) Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol 132:531\u2013543. https:\/\/doi.org\/10.1007\/s00401-016-1591-8","journal-title":"Acta Neuropathol"},{"key":"12145_CR5","doi-asserted-by":"publisher","first-page":"e1367","DOI":"10.1212\/wnl.0000000000012639","volume":"97","author":"C Gaig","year":"2021","unstructured":"Gaig C, Compta Y, Heidbreder A et al (2021) Frequency and characterization of movement disorders in anti-IgLON5 disease. Neurology 97:e1367\u2013e1381. https:\/\/doi.org\/10.1212\/wnl.0000000000012639","journal-title":"Neurology"},{"key":"12145_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/brain\/awx189","volume":"141","author":"B Balint","year":"2018","unstructured":"Balint B, Vincent A, Meinck H-M et al (2018) Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain 141:13\u201336. https:\/\/doi.org\/10.1093\/brain\/awx189","journal-title":"Brain"},{"key":"12145_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ et al (2020) Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94:743\u2013755. https:\/\/doi.org\/10.1212\/WNL.0000000000009323","journal-title":"Neurology"},{"key":"12145_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"12145_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/WCO.0000000000000677","volume":"32","author":"C Gaig","year":"2019","unstructured":"Gaig C, Compta Y (2019) Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease. Curr Opin Neurol 32:493\u2013499. https:\/\/doi.org\/10.1097\/WCO.0000000000000677","journal-title":"Curr Opin Neurol"},{"key":"12145_CR10","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863\u20131872. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"key":"12145_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","volume":"89","author":"G Rizzo","year":"2018","unstructured":"Rizzo G, Arcuti S, Copetti M et al (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89:358\u2013366. https:\/\/doi.org\/10.1136\/jnnp-2017-316844","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12145_CR12","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3389\/fneur.2019.01056","volume":"10","author":"MS Nissen","year":"2019","unstructured":"Nissen MS, Blaabjerg M (2019) Anti-IgLON5 disease: a case with 11-year clinical course and review of the literature. Front Neurol 10:1056. https:\/\/doi.org\/10.3389\/fneur.2019.01056","journal-title":"Front Neurol"},{"key":"12145_CR13","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","volume":"4","author":"JA Honorat","year":"2017","unstructured":"Honorat JA, Komorowski L, Josephs KA et al (2017) IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflammation 4:e385. https:\/\/doi.org\/10.1212\/NXI.0000000000000385","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"12145_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200137","author":"AEM Bastiaansen","year":"2023","unstructured":"Bastiaansen AEM, van Steenhoven RW, Te Vaarwerk ES et al (2023) Antibodies associated with autoimmune encephalitis in patients with presumed neurodegenerative dementia. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000200137","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12145_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/ane.13207","volume":"141","author":"P Cabezudo-Garc\u00eda","year":"2020","unstructured":"Cabezudo-Garc\u00eda P, Mena-V\u00e1zquez N, Estivill Torr\u00fas G et al (2020) Response to immunotherapy in anti-IgLON5 disease: a systematic review. Acta Neurol Scand 141:263\u2013270. https:\/\/doi.org\/10.1111\/ane.13207","journal-title":"Acta Neurol Scand"},{"key":"12145_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006\u20131012. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005","journal-title":"J Clin Epidemiol"},{"key":"12145_CR17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"12145_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37:1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"12145_CR19","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi RMP, Lisy KMP-F (2017) Joanna briggs institute reviewer\u2019s manual. In: Joanna Briggs Institute Reviewer\u2019s Manual. https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL\/4687372\/Chapter+7%3A+Systematic+reviews+of+etiology+and+risk"},{"key":"12145_CR20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.25037","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Arnulf I, Hogl B et al (2012) A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord 27:913\u2013916. https:\/\/doi.org\/10.1002\/mds.25037","journal-title":"Mov Disord"},{"key":"12145_CR21","doi-asserted-by":"publisher","first-page":"e2801 LP-e2811","DOI":"10.1212\/WNL.0000000000012060","volume":"96","author":"G Roberts","year":"2021","unstructured":"Roberts G, Durcan R, Donaghy PC et al (2021) Accuracy of cardiac innervation scintigraphy for mild cognitive impairment with lewy bodies. Neurology 96:e2801 LP-e2811. https:\/\/doi.org\/10.1212\/WNL.0000000000012060","journal-title":"Neurology"},{"key":"12145_CR22","doi-asserted-by":"publisher","first-page":"632497","DOI":"10.3389\/fneur.2021.632497","volume":"12","author":"J El Shazly","year":"2021","unstructured":"El Shazly J, Juenemann M, Gerriets T et al (2021) Case report: neuropsychological findings in IgLON5 antibody disorder. Front Neurol 12:632497. https:\/\/doi.org\/10.3389\/fneur.2021.632497","journal-title":"Front Neurol"},{"key":"12145_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2016.09.012","volume":"300","author":"R Haitao","year":"2016","unstructured":"Haitao R, Yingmai Y, Yan H et al (2016) Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy. J Neuroimmunol 300:9\u201310. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.09.012","journal-title":"J Neuroimmunol"},{"key":"12145_CR24","doi-asserted-by":"publisher","first-page":"800298","DOI":"10.3389\/fneur.2022.800298","volume":"13","author":"Y Fu","year":"2022","unstructured":"Fu Y, Zou X, Liu L (2022) Epileptic seizures and right-sided hippocampal swelling as presenting symptoms of anti-IgLON5 disease: a case report and systematic review of the literature. Front Neurol 13:800298. https:\/\/doi.org\/10.3389\/fneur.2022.800298","journal-title":"Front Neurol"},{"key":"12145_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB consortium. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"12145_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/psyg.12586","volume":"20","author":"K Utsumi","year":"2020","unstructured":"Utsumi K, Fukatsu R, Yamada R et al (2020) Characteristics of initial symptoms and symptoms at diagnosis in probable dementia with Lewy body disease: incidence of symptoms and gender differences. Psychogeriatrics 20:737\u2013745. https:\/\/doi.org\/10.1111\/psyg.12586","journal-title":"Psychogeriatrics"},{"key":"12145_CR27","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/brain\/awz111","volume":"142","author":"SM Fereshtehnejad","year":"2019","unstructured":"Fereshtehnejad SM, Yao C, Pelletier A et al (2019) Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: a prospective study. Brain 142:2051\u20132067. https:\/\/doi.org\/10.1093\/brain\/awz111","journal-title":"Brain"},{"key":"12145_CR28","doi-asserted-by":"publisher","first-page":"105279","DOI":"10.1016\/j.parkreldis.2023.105279","volume":"107","author":"C Mellergaard","year":"2023","unstructured":"Mellergaard C, Waldemar G, Vogel A et al (2023) Characterising the prodromal phase in dementia with Lewy bodies. Parkinsonism Relat Disord 107:105279. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105279","journal-title":"Parkinsonism Relat Disord"},{"key":"12145_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13195-018-0417-4","volume":"10","author":"A Mouton","year":"2018","unstructured":"Mouton A, Blanc F, Gros A et al (2018) Sex ratio in dementia with Lewy bodies balanced between Alzheimer\u2019s disease and Parkinson\u2019s disease dementia: a cross-sectional study. Alzheimer\u2019s Res Ther 10:92. https:\/\/doi.org\/10.1186\/s13195-018-0417-4","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"12145_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz133","author":"C Gaig","year":"2019","unstructured":"Gaig C, Iranzo A, Cajochen C et al (2019) Characterization of the sleep disorder of anti-IgLON5 disease. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsz133","journal-title":"Sleep"},{"key":"12145_CR31","doi-asserted-by":"publisher","first-page":"9421098","DOI":"10.1155\/2018\/9421098","volume":"2018","author":"P-C Chan","year":"2018","unstructured":"Chan P-C, Lee H-H, Hong C-T et al (2018) REM sleep behavior disorder (RBD) in dementia with lewy bodies (DLB). Behav Neurol 2018:9421098. https:\/\/doi.org\/10.1155\/2018\/9421098","journal-title":"Behav Neurol"},{"key":"12145_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00702-021-02300-8","volume":"128","author":"P Bugalho","year":"2021","unstructured":"Bugalho P, Salavisa M, Serrazina F et al (2021) REM sleep absence in patients referred to polysomnography for REM sleep behavior disorder. J Neural Transm 128:191\u2013198. https:\/\/doi.org\/10.1007\/s00702-021-02300-8","journal-title":"J Neural Transm"},{"key":"12145_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2377-13-140","volume":"13","author":"E Londos","year":"2013","unstructured":"Londos E, Hanxsson O, Alm Hirsch I et al (2013) Dysphagia in Lewy body dementia\u2014a clinical observational study of swallowing function by videofluoroscopic examination. BMC Neurol 13:140. https:\/\/doi.org\/10.1186\/1471-2377-13-140","journal-title":"BMC Neurol"},{"key":"12145_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/archneur.58.2.259","volume":"58","author":"J M\u00fcller","year":"2001","unstructured":"M\u00fcller J, Wenning GK, Verny M et al (2001) Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 58:259\u2013264. https:\/\/doi.org\/10.1001\/archneur.58.2.259","journal-title":"Arch Neurol"},{"key":"12145_CR35","doi-asserted-by":"publisher","unstructured":"Presti MF, Schmeichel AM, Low PA, et al (2014) Degeneration of Brainstem Respiratory Neurons in Dementia with Lewy Bodies Sleep 37(2) 373\u2013378. https:\/\/doi.org\/10.5665\/sleep.3418","DOI":"10.5665\/sleep.3418"},{"key":"12145_CR36","doi-asserted-by":"publisher","first-page":"e002870","DOI":"10.1136\/bmjopen-2013-002870","volume":"3","author":"S Hibi","year":"2013","unstructured":"Hibi S, Yamaguchi Y, Umeda-Kameyama Y et al (2013) Respiratory dysrhythmia in dementia with Lewy bodies: a cross-sectional study. BMJ Open 3:e002870. https:\/\/doi.org\/10.1136\/bmjopen-2013-002870","journal-title":"BMJ Open"},{"key":"12145_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000605","author":"C Gaig","year":"2019","unstructured":"Gaig C, Ercilla G, Daura X et al (2019) HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000605","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12145_CR38","doi-asserted-by":"publisher","first-page":"852215","DOI":"10.3389\/fimmu.2022.852215","volume":"13","author":"N Madetko","year":"2022","unstructured":"Madetko N, Marzec W, Kowalska A et al (2022) Anti-IgLON5 disease\u2014the current state of knowledge and further perspectives. Front Immunol 13:852215. https:\/\/doi.org\/10.3389\/fimmu.2022.852215","journal-title":"Front Immunol"},{"key":"12145_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-022-03044-y","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang L, Wang Y (2023) Anti-IgLON5 disease complicated with rectal adenocarcinoma: a case report. BMC Neurol 23:1\u20135. https:\/\/doi.org\/10.1186\/s12883-022-03044-y","journal-title":"BMC Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-12145-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:11:38Z","timestamp":1711548698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-12145-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["12145"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-12145-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest, financial or other concerning the present work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of<!--Emphasis Type='Bold' removed--> interest"}},{"value":"Institutional review board approval was not required for this work. Informed patient consent was not necessary for this work. We confirm that we have read the journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}